Current Molecular Medicine
Title: Preface [Hot topic: HLA-B27 and Spondyloarthropathies Thirty Years Later (Executive Editor: Robert A. Colbert)]
Volume: 4 Issue: 1
Author(s): Robert A. Colbert
Affiliation:
Export Options
About this article
Cite this article as:
Colbert A. Robert, Preface [Hot topic: HLA-B27 and Spondyloarthropathies Thirty Years Later (Executive Editor: Robert A. Colbert)], Current Molecular Medicine 2004; 4 (1) . https://dx.doi.org/10.2174/1566524043479266
DOI https://dx.doi.org/10.2174/1566524043479266 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
11
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Genetic Susceptibility to Ankylosing Spondylitis
Current Molecular Medicine HLA-B27 is a Risk Factor for Rheumatoid Arthritis: Suggestion for an Evidence-based Update
Current Pharmacogenomics and Personalized Medicine Epidemiology of Spondyloarthritis in Asian Countries and Regions
Current Rheumatology Reviews Annexin A5 Imaging: An Academic Research – Clinical Trials and Theses
Current Molecular Imaging (Discontinued) The Long-Term Outcome of Juvenile Idiopathic Arthritis
Current Rheumatology Reviews Anti-Tumor Necrosis Factor-α Therapy in Undifferentiated Spondyloarthritis (USpA)
Current Rheumatology Reviews p53 Peptide Prevents LITAF-Induced TNF-Alpha-Mediated Mouse Lung Lesions and Endotoxic Shock
Current Molecular Medicine Advances in Biologic Agents for the Treatment of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry “Bedside-to-Bench” Behavioral Outcomes in Animal Models of Pain: Beyond the Evaluation of Reflexes
Current Neuropharmacology Potential Role of Bioactive Lipids in Rheumatoid Arthritis
Current Pharmaceutical Design TLR Signaling Pathways: Opportunities for Activation and Blockade in Pursuit of Therapy
Current Pharmaceutical Design Update on the Management of Spondyloarthritis in Asian Countries
Current Rheumatology Reviews The Immunobiology of HLA-B27: Variations on a Theme
Current Molecular Medicine Inhibitors of TACE and Caspase-1 As Anti-inflammatory Drugs
Current Medicinal Chemistry Quantitative Structure Activity Relationship (QSAR) Analysis of Substituted 4-Oxothiazolidines and 5-Arylidines as Lipoxygenase Inhibitors
Mini-Reviews in Medicinal Chemistry Osteogenic Differentiation Factors of Multipotent Mesenchymal Stromal Cells in the Current Understanding
Current Pharmaceutical Design History and Milestones of Mouse Models of Autoimmune Diseases
Current Pharmaceutical Design Novel Controlled Release Solid Dispersion for the Delivery of Diclofenac Sodium
Current Drug Delivery Deep Venous Thrombosis Associated with Thalidomide use in a Case of Steroid Dependent Erythema Nodosum Leprosum-a Management Conundrum
Current Drug Safety Quantification of Etodolac in Human Plasma for Pharmacokinetics and Bioequivalence Studies in 27 Korean Subjects
Drug Metabolism Letters